# Deborah Jackson

> Deborah Jackson is a Series B investor at JumpThru (New York) backing EdTech and GovTech. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [JumpThru](https://shizune.co/investors/profile/jumpthru)
- Location: New York, United States
- Total investments: 6
- Last investment: Aug 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/deborahbjackson
- X (Twitter): http://twitter.com/dbdj1007
- Website: http://www.plumalley.co
- Facebook: https://www.facebook.com/DeborahBureshJackson

Deborah Jackson is a Series B investor at JumpThru in New York focused on EdTech and GovTech. Deborah Jackson is based out of New York, New York and is the Chief Executive Officer and Founder of JumpThru. Deborah previously worked at Women Innovate Mobile as a Founder. Deborah Jackson attended Columbia Graduate School of Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| EdTech | 1 | 17% |
| GovTech | 1 | 17% |
| Software | 1 | 17% |
| Education | 1 | 17% |
| E-Learning | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Seed | 1 | 17% |
| Series A | 1 | 17% |
| Funding Round | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Openwater | Openwater is developing a new generation of imaging technologies, with high resolution and low costs, enabling medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications | $54M | Venture - Series Unknown | Aug 22, 2024 |  |
| Aclima | Aclima has pioneered an entirely new way to measure and analyze air pollution and greenhouse gases, block by block and around the world. The Aclima hardware and software technology platform translates billions of scientific measurements from its network of stationary and roving sensors into environmental intelligence for governments, businesses,and communities. A Public Benefit Corporation, Aclima is dedicated to catalyzing bold action to protect public health, reduce climate-changing emissions and advance equity. The company holds a broad patent portfolio for networked, indoor, wearable, and mobile air quality sensing technologies. Aclima is headquartered in San Francisco with offices in Portland and New York City. For more information please visit https://aclima.io. | $40M | Series B | Nov 19, 2020 |  |
| Aclima | Aclima has pioneered an entirely new way to measure and analyze air pollution and greenhouse gases, block by block and around the world. The Aclima hardware and software technology platform translates billions of scientific measurements from its network of stationary and roving sensors into environmental intelligence for governments, businesses,and communities. A Public Benefit Corporation, Aclima is dedicated to catalyzing bold action to protect public health, reduce climate-changing emissions and advance equity. The company holds a broad patent portfolio for networked, indoor, wearable, and mobile air quality sensing technologies. Aclima is headquartered in San Francisco with offices in Portland and New York City. For more information please visit https://aclima.io. |  | Series A | Jun 26, 2018 |  |
| Vyv | Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well asa licensing model for consumer and residential products. | $4.1M |  | Jan 25, 2018 |  |
| Vyv | Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well asa licensing model for consumer and residential products. |  | Seed | Jan 25, 2018 |  |
| ThinkCERCA | ThinkCERCA’s personalized literacy platform helps educators teach critical thinking skills through argumentative writing. With students and teachers using its platform in all 50 states and 130 countries, the company has partnered with prominent education leaders, including Follett Corporation, and has been featured by The Atlantic and EdSurge. A2016 SIAA CODiE Awards finalist in the Best Learning Capacity-Building Solution and Best Reading/English/Language Arts Instructional Solution categories, ThinkCERCA has also been named one of the best tools in ed tech by Common Sense’s Graphite. In July 2013, ThinkCERCA was the recipient of a Bill & Melinda Gates Foundation Literacy Courseware Challenge grant, and in December 2012, graduated from the inaugural class of Impact Engine’s social impact accelerator. To learn more, please visit ThinkCERCA.com | $10.1M | Series B | Sep 20, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Connectivity Ventures Fund](https://shizune.co/investors/profile/connectivity-capital) — VC Fund, 2 deals together
- [Rethink Impact](https://shizune.co/investors/profile/rethink-impact) — VC Fund, 2 deals together
- [Schmidt Family Foundation](https://shizune.co/investors/profile/schmidt-family-foundation) — VC Fund, 2 deals together
- [Social Capital](https://shizune.co/investors/profile/social-capital) — VC Fund, 2 deals together
- [ACVC Partners](https://shizune.co/investors/profile/acvc-partners) — VC Fund, 1 deal together
- [BELLE Capital](https://shizune.co/investors/profile/belle-capital) — VC Fund, 1 deal together

## About JumpThru

VC Fund



1 contacts available at JumpThru.

| Name | Title | Profile |
| --- | --- | --- |
| Deborah Jackson | CEO & Founder | https://shizune.co/investors/profile/deborah-jackson |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Deborah Jackson invest in?

Deborah Jackson invests primarily in EdTech, GovTech and Software startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Deborah Jackson last invest?

The most recent investment recorded for Deborah Jackson closed in Aug 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co